bortezomib,dexamethasone,lenalidomide
takeda
['multiple myeloma', 'triplet', 'determination']
determination trial: newly diagnosed multiple myeloma patients treated w/a triplet of drugs had longer pfs if they received an asct soon after drug therapy than if they simply had their stem cells collected for a possible future transplant. #asco22
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.